There has been a flurry of discussion about the problems MD/PhD's face as they progress in their careers. Some seem frustrated that few have proposed solutions. A recent white paper from the NIH advocated changing funding for trainees from investigator grants to training grants:
http://www.nationalpostdoc.org/inde...news/669-2012-nih-biomedical-workforce-report. The end result would be that training grants would be administered by departments and divisions and independently reviewed based on how successful their trainees are in terms of publication, time of training, and career outcomes. Currently investigator grants are reviewed by how successful their science is, not how their trainees do. The end result is that trainees are generally not treated well, and there is no accountability for churning out PhDs who find their career options quite limited.
Do you think making this change would address some of the issues? What problems do you see with this?
It's worth discussion because this is a change that actually could be implemented, and you could contact people at the NIH to advocate for it.
I think this is a good idea. I believe another suggestion in that white paper was to set a hard cap on the number of years that would be funded for PhD. After those years were expired, either the student would graduate, or the PI would have to divert money from their main research grants to pay for the trainee's funding. To make this more potent, they should mandate graduation.
IMO there is an over supply of PhDs. I would cut funding for PhD training. Supply and demand should restore some balance in the academic and industry marketplace.
A corollary is to make quals much more relevant. Nowadays, virtually everyone passes their quals. I think that they should postpone quals until about 3 years in. At that point, with only 2 years left on your training grant, it should be pretty clear whether somebody is going to complete his PhD. Let the quals sort out who deserves to graduate and who doesn't, and award a Masters to those who don't make the cut. They could even introduce two rounds of quals, one after year 1 and another after year 3, with attrition after year 1 due to people who simply can't hack it, and attrition after year 3 due to people who won't finish by 5 years.
I believe these would be positive steps, but that the scientific enterprise is more generally dysfunctional. Most papers are erroneous and not reproducible (e.g. see 2012 Nature paper where a team of 100 from Amgen could only reproduce 6 of 53 papers published in prestigious journals). I think that the NIH should form an Institute for Replication, and a huge chunk of the budget should go towards replication studies. They could either say that you can't publish until we've reproduced your paper, or they could say: go ahead and publish it, but if it proves not to be reproducible, you have to pay back the money and retract the paper. We need to move away from a system in which all that matters is publishing fashionable papers in trendy journals, and towards a system in which the quality of a career rests on the validity of one's findings.
Another easy step would be to discourage mega-papers. It just takes too damn long to publish nowadays, especially "high-impact" papers. I think it slows down science, and places too much emphasis on forming a coherent story that is mostly data massage.
Similarly, incentivize publication of negative data and replication studies. Easy to do: just consider them of value during grant applications.
Ensure reproducibility by mandating that all NIH-funded data be made publicly available on a weekly or monthly basis. People couldn't get by with data obfuscation if all primary data was easily referenced online.
I have more off the wall ideas. Probability of acceptance: zero. The sad fact of the matter is that the people in charge are happy with the current system. Where is their incentive to change it? You will notice that none of the "recommendations" from that panel - which met for 2 years - have any teeth at all. It was really just a show trial to ease discontent. The impetus will have to come externally, i.e. the public and especially Congress.